UCSF Scientists Use Human Stem Cells to Generate Immune System in Mice
Raising hopes for cell-based therapies, UCSF researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.

University of California San Francisco
Raising hopes for cell-based therapies, UCSF researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.
University of California President Mark G. Yudof today presented the UC Board of Regents with a report that charted the significant changes of the past six years and offered a candid assessment of how UC is performing.
Chancellor Susan Desmond-Helllmann, MD, MPH, presented awards to 11 members of the UC San Francisco community for their extraordinary contributions to the University and beyond.
Scott Reeves, PhD, director of the Center for Innovation in Interprofessional Education at UC San Francisco, has been named to the National Advisory Council of the National Center for Interprofessional Practice and Education.
Shinya Yamanaka's Nobel Prize for stem cell research brought fresh attention to something UCSF long ago sensed and seized: the promise of regeneration medicine for repairing or replacing damaged cells, tissues, and even whole organs.
Researchers at UC San Francisco have found that giving small amounts of formula in the first few days of life to infants experiencing high levels of early weight loss actually can increase the length of time their mothers end up breastfeeding.
UC San Francisco, a frequent high-performing team at AIDS Walk San Francisco, will again for the gold – the honor given to the top fundraising organizations participating in the annual event.
The American Federation of State, County and Municipal Employees union announced on May 10 that its patient care technical workers unit will strike on May 21 and 22 across the University of California system.
As part of efforts to reduce the cost of health care while also improving quality, the UCSF Center for Healthcare Value has announced winners of its "Caring Wisely" initiative.
Two UCSF scientists — brain researcher Michael Brainard, PhD, and cell biologist Dyche Mullins, PhD — have been selected to be Howard Hughes Medical Institute investigators.
A genetic test that measures cell cycle progression — an indicator of how rapidly cancer cells are growing and dividing — can be a useful tool for predicting who will have a recurrence of prostate cancer, according to researchers at UCSF.